Tag Archive for: clinical trials

The Biggest Psychedelic News Stories of the Week - September 11th

The Biggest Psychedelic News Stories of the Week – September 11th

, ,
California stands on the cusp of a psychedelic revolution with the TREAT Act and a landmark bill on 'magic mushrooms,' even as Michigan, Congress, and global initiatives from Sweden to Canada expand the horizons of mental health, addiction treatment, and veteran care.
Over One-Third of Under 50s Open to Psychedelic Trials for Mental Health Treatment

Over One-Third of Under 50s Are Open to Psychedelic Trials for Mental Health Treatment

Aside from psilocybin, those aged between 18-24 were most interested psychedelic trials with ketamine (27%) and MDMA (26%).
Will the UK’s Ambitious Life Sciences Investment Power-Up the Psychedelic Sector?

Will the UK’s Ambitious Life Sciences Investment Power-Up the Psychedelic Sector?

,
As an emerging innovative sector addressing unmet mental health needs, psychedelic drug developers are poised to greatly benefit from the diverse initiatives offered within this package. 
Adverse Effects in Psychedelic Clinical Trials

Adverse Events in Psychedelic Clinical Trials are Underreported

New research shows that enthusiasm for psychedelic treatments makes it easy to ignore adverse events in psychedelic clinical trials

Psychedelic Clinical Trials and the Michael Pollan Effect

,
With the incredible popularity of “How to Change Your Mind,” Michael Pollan sells people on psychedelic treatments that are not yet available
Psychedelic Clinical Trials

Three Phase 3 Clinical Trials that Could Legalize Psychedelics

,
The road to psychedelic legalization has many paths. These 3 clinical trials have the best chances to legalize psychedelics for therapy
Microdosing clinical trialsSutterstock

3 Microdosing Clinical Trials to Keep an Eye On

,
Does microdosing psychedelics work, or is it the placebo effect? Here are 3 microdosing clinical trials looking for answers
Psychedelic Business Spotlight - June 17

Psychedelic Business Spotlight – June 17

, ,
This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin moves closer to clinical trials, and more!